Skip to content

Hyperbaric Levobupivacaine for Spinal Anaesthesia

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01938755
Enrollment
73
Registered
2013-09-10
Start date
2013-06-30
Completion date
2014-01-31
Last updated
2017-04-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

This Study Was Focused on Selective Spinal Anesthesia for Lower Extremity Surgery in Order to Achieve Early Mobilization and to Shorten Hospital Stay

Brief summary

Spinal anaesthesia also called spinal block or sub-arachnoid block (SAB), is a form of regional anaesthesia involving injection of a local anaesthetic into the subarachnoid space, generally through a fine needle. There is no generic hyperbaric form of levobupivacaine currently available so we aimed in this study that to find the appropriate concentration of the levobupivacaine which achieves unilateral spinal anesthesia. The potential benefits of this type of anesthesia are less motor blockade and urinary retention, decrease in hospital stay. Therefore, it seems to be suitable for outpatient anesthesia.

Interventions

DRUGlevobupivacaine

levobupivacaine plus 60 mg dextrose

Sponsors

Ordu University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Approval to participate in the study and spinal anesthesia * American society of anesthesia (ASA) I,II physical status * Scheduled for lower extremity surgery

Exclusion criteria

* Refuse to participate in the study * American society of anesthesia (ASA)III, IV physical status * Hypersensitivity to local anesthetics * Emergency surgery * Chronic pain treatment * Peripheral neuropathy * Severe systemic disease

Design outcomes

Primary

MeasureTime frame
degree of motor blockadeuntil dissolve of motor blockade

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026